jfinison

Author's posts

How providers can innovate to combat physician burnout

Increasingly, health leaders are recognizing the need to utilize one or more approaches to the multifaceted problem.

How providers can innovate to combat physician burnout

Increasingly, health leaders are recognizing the need to utilize one or more approaches to the multifaceted problem.

Social determinants are threatening patient outcomes, burnout is a scourge but opioid scripts are down, physicians say

Majority say social determinants pose major threat to patient health and burnout threatens three-quarters, but patient relationships are a major boost.

Veterans Affairs report shows VA hospitals making strides in quality

About 71 percent of its total facilities have shown improvement, according to the internal report, with several no longer considered high-risk.

Low consumer health fluency could lead to billions in tax savings on table during open enrollment

Part of the issue is that consumers are often undisciplined about saving in general, and lack the necessary vocabulary for financial communication.

CMS: Innovative new payment models are coming — and some will be mandatory

CMS has made it clear that it wants health systems to share the risk of cost and outcomes.

Hospital supply chain directors brace for impact from Trump tariff threats

Affected supplies include consumables, pacemakers, computers and MRI machines.

HHS doles out more than $1 billion in grants to various HHS orgs to fight opioid epidemic

Largest sum went to the Substance Abuse and Mental Health Services Administration to focus on increasing access to medication-assisted treatment.

For-profit hospitals correlated with higher readmission rates, study finds

CMS levies reimbursement penalties against hospitals that underperform on 30-day readmission rates, leaving for-profit hospitals at a disadvantage.

DOJ wants Aetna, CVS Health to divest Part D plans before merger approval

The antitrust concern over the Medicare prescription drug plans is holding up approval of the $69 billion deal.